Post by
ScienceFirst on Jun 21, 2022 8:54am
The potential to be the next SOC
"Based on the strength of the clinical data collected and the consistently high safety and efficacy profile of Theralase®’s PDT, I am confident that TLD-1433-based therapy has the potential to become the next gold-standard in the treatment of BCG-Unresponsive patients.”
Comment by
Lesalpes29 on Jun 21, 2022 8:58am
Que dire de plus! Positive sentence!